These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21084783)

  • 1. Efficacy and safety of olmesartan medoxomil in patients with stage 1 hypertension: blood pressure lowering and goal achievement.
    Wilford Germino F
    Postgrad Med; 2010 Nov; 122(6):57-67. PubMed ID: 21084783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR; Shojaee A; Maa JF
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
    Ram CV; Sachson R; Littlejohn T; Qian C; Shojaee A; Stoakes KA; Neutel JM
    Am J Cardiol; 2011 May; 107(9):1346-52. PubMed ID: 21497211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
    Rump LC; Sellin L
    Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA; Shojaee A; Maa JF; Neutel JM
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG; Weber MA; Wang AC; Hinman DJ
    Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertension.
    Flack JM; Graff A; Li W; Chavanu KJ
    Postgrad Med; 2012 May; 124(3):59-70. PubMed ID: 22691900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW; Neutel JM; Dubiel R; Maa JF; Chavanu KJ
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):325-33. PubMed ID: 22920048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
    Rump LC; Girerd X; Sellin L; Stegbauer J
    J Hum Hypertens; 2011 Sep; 25(9):565-74. PubMed ID: 21107435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
    Neutel JM; Smith DH; Silfani TN; Lee Y; Weber MA
    J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.
    Weir MR; Punzi HA; Flack JM; Stoakes KA; Chavanu KJ; Li W; Dubiel R
    Postgrad Med; 2011 Jan; 123(1):80-7. PubMed ID: 21293087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK; Weir MR
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.
    Chrysant SG
    Clin Drug Investig; 2010; 30(7):473-82. PubMed ID: 20528002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.